NCT02381587View on ClinicalTrials.gov

the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Sjogren Syndrome Patients

UnknownOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Primary Sjogren Syndrome With Multisystem Involvement

Interventions

OTHER

Retrospective study

no interventional study - Retrospective study that valuate The effect of HCQ treatment in cardiovascular AVENTS IN patients with primary sjogren syndrome